Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Publication year range
1.
Data Brief ; 54: 110480, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38725554

ABSTRACT

Roselle (Hibiscus sabdariffa L.) is a worldwide known species of great importance due to its medicinal properties and pleasant flavor. In Paraguay, it is used as an alternative crop by family-run farmers; however, the varieties used in the country are unknown, so no information is available on this crop. The qualitative characterization would collect knowledge serving as a basis for the registration of varieties produced in Paraguay. In addition, such data are useful for future genetic improvement programs considering this crop. The present work was carried out at the Multidisciplinary Center for Technological Research and the experimental farmland of the Faculty of Agricultural Sciences of the National University of Asuncion, during the years 2022 and 2023. The main objective was to carry out a morphological characterization of four Roselle varieties: Ana Delia, Benito, Dogo, and Creole. The design consisted of completely randomized blocks, with four treatments (varieties) and four replications; each experimental unit (block) was composed of 24 plants, distributed in four rows; 12 plants, selected from the central rows, were harvested for the evaluations. Stem color, leaf shape, leaf margin, rib color, petiole color, flower color, calyx color, calyx sepal opening, capsule shape, capsule color, capsule anthocyanin coloration, and pubescence level were evaluated. The results demonstrate qualitative differences between the varieties, which help to compare and classify them for a better variety selection.

2.
Gene Ther ; 22(11): 923-30, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26333349

ABSTRACT

Achieving persistent expression is a prerequisite for effective genetic therapies for inherited disorders. These proof-of-concept studies focused on adeno-associated virus (AAV) administration to newborn monkeys. Serotype rh10 AAV expressing ovalbumin and green fluorescent protein (GFP) was administered intravenously at birth and compared with vehicle controls. At 4 months postnatal age, a second injection was administered intramuscularly, followed by vaccination at 1 year of age with ovalbumin and GFP. Ovalbumin was highest 2 weeks post administration in the treated monkey, which declined but remained detectable thereafter; controls demonstrated no expression. Long-term AAV genome copies were present in myocytes. At 4 weeks, neutralizing antibodies to rh10 were present in the experimental animal only. With AAV9 administration at 4 months, controls showed transient ovalbumin expression that disappeared with the development of strong anti-ovalbumin and anti-GFP antibodies. In contrast, increased and maintained ovalbumin expression was noted in the monkey administered AAV at birth, without antibody development. After vaccination, the experimental monkey maintained levels of ovalbumin without antibodies, whereas controls demonstrated high levels of antibodies. These preliminary studies suggest that newborn AAV administration expressing secreted and intracellular xenogenic proteins may result in persistent expression in muscle, and subsequent vector administration can result in augmented expression without humoral immune responses.


Subject(s)
Antibodies, Neutralizing/immunology , Gene Transfer Techniques , Immune Tolerance/genetics , Animals , Animals, Newborn , Antibodies, Heterophile , Antibodies, Neutralizing/genetics , Dependovirus/genetics , Female , Genetic Therapy , Genetic Vectors/immunology , Immunity, Humoral/genetics , Immunity, Humoral/immunology , Macaca mulatta , Ovalbumin/blood , Ovalbumin/genetics , Pilot Projects
4.
Gene Ther ; 22(2): 111-5, 2015 02.
Article in English | MEDLINE | ID: mdl-25474440

ABSTRACT

Hyperammonemia is less severe in arginase 1 deficiency compared with other urea cycle defects. Affected patients manifest hyperargininemia and infrequent episodes of hyperammonemia. Patients typically suffer from neurological impairment with cortical and pyramidal tract deterioration, spasticity, loss of ambulation, seizures and intellectual disability; death is less common than with other urea cycle disorders. In a mouse model of arginase I deficiency, the onset of symptoms begins with weight loss and gait instability, which progresses toward development of tail tremor with seizure-like activity; death typically occurs at about 2 weeks of life. Adeno-associated viral vector gene replacement strategies result in long-term survival of mice with this disorder. With neonatal administration of vector, the viral copy number in the liver greatly declines with hepatocyte proliferation in the first 5 weeks of life. Although the animals do survive, it is not known from a functional standpoint how well the urea cycle is functioning in the adult animals that receive adeno-associated virus. In these studies, we administered [1-13C] acetate to both littermate controls and adeno-associated virus-treated arginase 1 knockout animals and examined flux through the urea cycle. Circulating ammonia levels were mildly elevated in treated animals. Arginine and glutamine also had perturbations. Assessment 30 min after acetate administration demonstrated that ureagenesis was present in the treated knockout liver at levels as low at 3.3% of control animals. These studies demonstrate that only minimal levels of hepatic arginase activity are necessary for survival and ureagenesis in arginase-deficient mice and that this level of activity results in control of circulating ammonia. These results may have implications for potential therapy in humans with arginase deficiency.


Subject(s)
Dependovirus/genetics , Hyperargininemia/therapy , Ammonia/blood , Animals , Arginase/genetics , Arginase/metabolism , Disease Models, Animal , Genetic Therapy , Hyperammonemia/blood , Hyperammonemia/genetics , Hyperammonemia/therapy , Hyperargininemia/blood , Hyperargininemia/genetics , Liver/enzymology , Liver/pathology , Mice , Mice, Knockout
5.
Mutagenesis ; 21(5): 321-5, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16950806

ABSTRACT

Luteolin and quercetin are widely distributed plant flavonoids that possess a variety of chemical and biological activities, including free-radical scavenging and antioxidant activity. Recently, both flavonoids have been reported to inhibit DNA topoisomerases I and II (topo I and topo II), a property that, together with their ability to induce DNA and chromosome damage, has made them candidate anticancer compounds. In the present study, we confirmed that both compounds are topo II inhibitors by conducting a comparative study of their effect on topo II activity from Chinese hamster ovary AA8 cells. Because interference with the function of topo II to resolve DNA entanglement at the end of replication results in chromosome malsegregation at mitosis, we investigated whether luteolin and quercetin are effective in inducing endoreduplication in AA8 cells. Concentrations of luteolin and quercetin that inhibited topo II catalytic activity resulted in extraordinarily high yields of metaphases showing diplochromosomes. Given the established relationship of polyploidy with tumor development via aneuploidy and genetic instability, these results question the usefulness of luteolin and quercetin in cancer therapy.


Subject(s)
Chromosome Aberrations/chemically induced , Flavonoids/adverse effects , Luteolin/adverse effects , Quercetin/adverse effects , Topoisomerase II Inhibitors , Animals , Antineoplastic Agents/adverse effects , Antineoplastic Agents/pharmacology , Cells, Cultured , Chromosome Segregation/drug effects , Cricetinae , DNA Damage/drug effects , DNA Topoisomerases, Type II/metabolism , Enzyme Inhibitors/pharmacology , Models, Biological , Polyploidy
6.
Rev. chil. cir ; 41(4): 360-2, dic. 1989. tab
Article in Spanish | LILACS | ID: lil-82558

ABSTRACT

Se presenta un caso clínico de hemobilia, cuya etiología corresponde a una malformación vascular de la submucosa vesicular denominada aneurisma cirsoideo. Esta malformación es en todo semejante a la descrita en la submucosa de otros órganos como estómago, colon y vejiga urinaria. El mecanismo de erosión de la arteria, está dado por la presencia de cálculos que permanentemente lesionan la mucosa. La intensidad de la hemorragia dependerá del calibre del vaso erosionado y, su exteriorización al intestino, de la amplitud del conducto cístico, de la permeabilidad del esfínter de Oddi y de la presencia de fístulas biliobiliares o biliodigestivas


Subject(s)
Humans , Female , Aneurysm/complications , Cholelithiasis/complications , Hemobilia/etiology , Gallbladder/injuries , Rupture
SELECTION OF CITATIONS
SEARCH DETAIL
...